News and Announcements
The Case for Investors Sticking out the Volatility in Bitcoin and Ethereum
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
During the Month of May, a price correction for bitcoin wiped off nearly $4 billion in its market value.
KEY TAKEAWAYS:
- Cryptocurrencies are partly becoming more popular because countries and companies are taking a closer look at the technology that underpins them: blockchain. Japan, for example, approved bitcoin as a legal payment method in April.
- For context: $100 of bitcoin bought in 2010 is worth more than $75 million in 2017.
- Analysts have made varied predictions about where prices and market capitalization for digital assets are headed.
- BTCC’s Lee told CNBC he expected the market cap for bitcoin to hit at least $1 trillion, if not more, by 2025
“We’re now sort of at … a tipping point, where people are now considering bitcoin or ethereum or digital assets as more mainstream,” Dave Chapman, managing director of Hong Kong-based commodities and digital assets trading house Octagon Strategy, told CNBC. “A lot of the people that we service are actually very comfortable with having 1 percent of their net worth into bitcoin or ethereum.”
To them, it’s “just a natural extension of all their diversification of their portfolio” that includes other asset classes such as properties, precious metals or index funds.
Chapman added that while volatility may be off-putting, the returns on digital asset classes remain extremely attractive to investors. He said, “There’s no other asset class in the world that could’ve given you the historic performance of this sector … the historic performance, which is obviously not representative of future earnings, … does appeal to a lot of people.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
